🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Laboratory and Clinical Data in Antiphospholipid Patients

Recruitingn/aAges 18 Years - anyAllCentral Hospital, Nancy, France
NCT04308564 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To constitute a registry of antiphospholipid antibodies positive-patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age between 18 and 60 years; * persistent (at least 12 weeks apart) aPL-positivity within 12 months prior to screening Exclusion Criteria: * no inform consent * impossible follow up * pregnancy
💊

What it tests

  • Blood test
📍

Where

2 sites
CHRU de Lille
Lille, France
CHRU de Nancy
Nancy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy